{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:08:30Z","timestamp":1792084110842,"version":"4.4.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,18]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Guanosine triphosphate cyclohydrolase 1 (GCH1) gene rs11158026 polymorphism was suggested to be associated with Parkinson disease (PD) risk; however, the conclusions remain controversial. Thus, we performed a meta-analysis to investigate the association between GCH1 rs11158026 polymorphism and PD susceptibility.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The literature was searched from electronic databases such as PubMed, Cochrane Library, Embase, Web of Science, and Chinese national knowledge infrastructure until March 1, 2024. The odds ratio (ORs) and 95% confidence intervals (95% CIs) were used to assess the relationship between the GCH1 rs11158026 polymorphism and PD susceptibility. Data analysis was processed by Stata 12.0 software.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Six articles with 4091 cases and 4863 controls were included in this meta-analysis. There was no significant association between GCH1 rs11158026 polymorphism and PD risk in all genetic models. In subgroup analysis by ethnicity showed a strong association in Caucasians (TT vs CT\u2005+\u2005CC: OR\u2005=\u20050.70, 95% CI\u2005=\u20050.55\u20130.90, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.005; TT vs CC: OR\u2005=\u20050.69, 95% CI\u2005=\u20050.52\u20130.92, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.011; T vs C: OR\u2005=\u20050.85, 95% CI\u2005=\u20050.74\u20130.98, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.025).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Our findings suggested that GCH1 rs11158026 polymorphism may be associated with PD susceptibility in Caucasians, but the results should be interpreted with caution due to insufficient evidence.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000042141","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T11:00:24Z","timestamp":1746529224000},"page":"e42141","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Association of GCH1 polymorphism with Parkinson disease susceptibility: A meta-analysis"],"prefix":"10.1097","volume":"104","author":[{"given":"Jinhua","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurology, The Quzhou Affiliated Hospital of Wenzhou Medical University (Quzhou People\u2019s Hospital), Quzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Quzhou Affiliated Hospital of Wenzhou Medical University (Quzhou People\u2019s Hospital), Quzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Quzhou Affiliated Hospital of Wenzhou Medical University (Quzhou People\u2019s Hospital), Quzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Zhan","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Quzhou Affiliated Hospital of Wenzhou Medical University (Quzhou People\u2019s Hospital), Quzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1096-0150","authenticated-orcid":false,"given":"Jiao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Quzhou Affiliated Hospital of Wenzhou Medical University (Quzhou People\u2019s Hospital), Quzhou, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250904","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","article-title":"Genetics and pathogenesis of Parkinson\u2019s syndrome.","volume":"18","author":"Ye","year":"2023","journal-title":"Annu Rev Pathol"},{"key":"R2-20250904","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson\u2019s disease.","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet"},{"key":"R3-20250904","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(10)62345-8","article-title":"Imputation of sequence variants for identification of genetic risks for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies.","volume":"377","author":"Nalls","year":"2011","journal-title":"Lancet"},{"key":"R4-20250904","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/brain\/awaa401","article-title":"Targeted sequencing of Parkinson\u2019s disease loci genes highlights SYT11, FGF20 and other associations.","volume":"144","author":"Rudakou","year":"2021","journal-title":"Brain"},{"key":"R5-20250904","doi-asserted-by":"crossref","first-page":"231.e1","DOI":"10.1016\/j.neurobiolaging.2018.09.008","article-title":"Common and rare GCH1 variants are associated with Parkinson\u2019s disease.","volume":"73","author":"Rudakou","year":"2019","journal-title":"Neurobiol Aging"},{"key":"R6-20250904","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40035-020-00212-3","article-title":"GCH1 variants contribute to the risk and earlier age-at-onset of Parkinson\u2019s disease: a two-cohort case-control study.","volume":"9","author":"Pan","year":"2020","journal-title":"Transl Neurodegener"},{"key":"R7-20250904","doi-asserted-by":"crossref","first-page":"221.e1","DOI":"10.1016\/j.neurobiolaging.2015.12.016","article-title":"Association of GCH1 and MIR4697, but not SIPA1L2 and VPS13C polymorphisms, with Parkinson\u2019s disease in Taiwan.","volume":"39","author":"Chen","year":"2016","journal-title":"Neurobiol Aging"},{"key":"R8-20250904","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2016.08.001","article-title":"SIPA1L2, MIR4697, GCH1 and VPS13C loci and risk of Parkinson\u2019s diseases in Iranian population: a case-control study.","volume":"369","author":"Safaralizadeh","year":"2016","journal-title":"J Neurol Sci"},{"key":"R9-20250904","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ajmg.b.32410","article-title":"Association of four new candidate genetic variants with Parkinson\u2019s disease in a Han Chinese population.","volume":"171B","author":"Wang","year":"2016","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R10-20250904","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R11-20250904","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"R13-20250904","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neulet.2017.04.003","article-title":"Polymorphism in MIR4697 but not VPS13C, GCH1, or SIPA1L2 is associated with risk of Parkinson\u2019s disease in a Han Chinese population.","volume":"650","author":"Yang","year":"2017","journal-title":"Neurosci Lett"},{"key":"R14-20250904","doi-asserted-by":"crossref","first-page":"159.e7","DOI":"10.1016\/j.neurobiolaging.2018.03.005","article-title":"Association analyses of variants of SIPA1L2, MIR4697, GCH1, VPS13C, and DDRGK1 with Parkinson\u2019s disease in East Asians.","volume":"68","author":"Zou","year":"2018","journal-title":"Neurobiol Aging"},{"key":"R15-20250904","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1523\/JNEUROSCI.0653-21.2021","article-title":"GCH1 deficiency activates brain innate immune response and impairs tyrosine hydroxylase homeostasis.","volume":"42","author":"Larbalestier","year":"2022","journal-title":"J Neurosci"},{"key":"R16-20250904","doi-asserted-by":"crossref","first-page":"147749","DOI":"10.1016\/j.gene.2023.147749","article-title":"GTP cyclohydroxylase1 (GCH1): Role in neurodegenerative diseases.","volume":"888","author":"Gupta","year":"2023","journal-title":"Gene"},{"key":"R17-20250904","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1002\/mds.22729","article-title":"GCH1 in early-onset Parkinson\u2019s disease.","volume":"24","author":"Cobb","year":"2009","journal-title":"Mov Disord"},{"key":"R18-20250904","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s007020200013","article-title":"Mutations of GCH1 in Dopa-responsive dystonia.","volume":"109","author":"Muller","year":"2002","journal-title":"J Neural Transm"},{"key":"R19-20250904","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1007\/s00415-018-8930-8","article-title":"GCH1 mutations in dopa-responsive dystonia and Parkinson\u2019s disease.","volume":"265","author":"Yoshino","year":"2018","journal-title":"J Neurol"},{"key":"R20-20250904","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.parkreldis.2015.01.004","article-title":"Novel GCH1 variant in Dopa-responsive dystonia and Parkinson\u2019s disease.","volume":"21","author":"Lewthwaite","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"issue":"Pt 9","key":"R21-20250904","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1093\/brain\/awu179","article-title":"Parkinson\u2019s disease in GTP cyclohydrolase 1 mutation carriers.","volume":"137","author":"Mencacci","year":"2014","journal-title":"Brain"},{"key":"R22-20250904","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.parkreldis.2016.05.010","article-title":"Low frequency of GCH1 and TH mutations in Parkinson\u2019s disease.","volume":"29","author":"Rengmark","year":"2016","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T12:01:54Z","timestamp":1756987314000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":21,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042141","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,18]]}}}